BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26185454)

  • 1. FH535 inhibited metastasis and growth of pancreatic cancer cells.
    Wu MY; Liang RR; Chen K; Shen M; Tian YL; Li DM; Duan WM; Gui Q; Gong FR; Lian L; Li W; Tao M
    Onco Targets Ther; 2015; 8():1651-70. PubMed ID: 26185454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway.
    Chen Y; Rao X; Huang K; Jiang X; Wang H; Teng L
    J Cancer; 2017; 8(16):3142-3153. PubMed ID: 29158786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis.
    Liu L; Zhi Q; Shen M; Gong FR; Zhou BP; Lian L; Shen B; Chen K; Duan W; Wu MY; Tao M; Li W
    Oncotarget; 2016 Jul; 7(30):47145-47162. PubMed ID: 27323403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FH535 inhibits proliferation and migration of colorectal cancer cells by regulating CyclinA2 and Claudin1 gene expression.
    Tu X; Hong D; Jiang Y; Lou Z; Wang K; Jiang Y; Jin L
    Gene; 2019 Mar; 690():48-56. PubMed ID: 30552982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FH535 inhibited migration and growth of breast cancer cells.
    Iida J; Dorchak J; Lehman JR; Clancy R; Luo C; Chen Y; Somiari S; Ellsworth RE; Hu H; Mural RJ; Shriver CD
    PLoS One; 2012; 7(9):e44418. PubMed ID: 22984505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FH535 inhibits the proliferation of HepG2 cells via downregulation of the Wnt/β-catenin signaling pathway.
    Liu J; Li G; Liu D; Liu J
    Mol Med Rep; 2014 Apr; 9(4):1289-92. PubMed ID: 24482011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FH535 Suppresses Osteosarcoma Growth
    Gustafson CT; Mamo T; Shogren KL; Maran A; Yaszemski MJ
    Front Pharmacol; 2017; 8():285. PubMed ID: 28588489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
    Yu L; Li X; Li H; Chen H; Liu H
    Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of FH535 on in vitro maturation of porcine oocytes by inhibiting WNT signaling pathway.
    Shi M; Cheng J; He Y; Jiang Z; Bodinga BM; Liu B; Chen H; Li Q
    Anim Sci J; 2018 Apr; 89(4):631-639. PubMed ID: 29284185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway.
    Liu QQ; Chen K; Ye Q; Jiang XH; Sun YW
    Cancer Cell Int; 2016; 16():57. PubMed ID: 27453691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation Promotes Progression of Pancreatic Cancer Through WNT/β-Catenin Pathway-Dependent Manner.
    Ren R; Yu J; Zhang Y; Wang SF; Guo X; Shen M; Xu MD; Jiang M; Zhi Q; Chen K; Tao M; Wu MY; Gu DM; Li W
    Pancreas; 2019 Sep; 48(8):1003-1014. PubMed ID: 31404031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Aryl benzenesulfonamide inhibitors of [3H]-thymidine incorporation and β-catenin signaling in human hepatocyte-derived Huh-7 carcinoma cells.
    Kril LM; Vilchez V; Jiang J; Turcios L; Chen C; Sviripa VM; Zhang W; Liu C; Spear B; Watt DS; Gedaly R
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3897-9. PubMed ID: 26243371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt signaling inhibitor FH535 selectively inhibits cell proliferation and potentiates imatinib-induced apoptosis in myeloid leukemia cell lines.
    Suknuntha K; Thita T; Togarrati PP; Ratanachamnong P; Wongtrakoongate P; Srihirun S; Slukvin I; Hongeng S
    Int J Hematol; 2017 Feb; 105(2):196-205. PubMed ID: 27766528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin inhibits proliferation and metastasis of canine mammary gland tumor cells through Wnt signaling axis.
    Xu E; Hu M; Liu Y
    Transl Cancer Res; 2021 Feb; 10(2):589-601. PubMed ID: 35116393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
    Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
    Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA colon cancer-associated transcript 2 may promote esophageal cancer growth and metastasis by regulating the Wnt signaling pathway.
    Wang X; Wang X
    Oncol Lett; 2019 Aug; 18(2):1745-1754. PubMed ID: 31423241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of miRNA-148a in pancreatic cancer reduces invasion and metastasis by inhibiting the Wnt/β-catenin signaling pathway via downregulating maternally expressed gene-3.
    Sun Y; Zhu Q; Zhou M; Yang W; Shi H; Shan Y; Zhang Q; Yu F
    Exp Ther Med; 2019 Jan; 17(1):639-648. PubMed ID: 30651845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of microRNA-940 promotes cell proliferation by targeting GSK3β and sFRP1 in human pancreatic carcinoma.
    Yang HW; Liu GH; Liu YQ; Zhao HC; Yang Z; Zhao CL; Zhang XF; Ye H
    Biomed Pharmacother; 2016 Oct; 83():593-601. PubMed ID: 27459115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
    Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
    Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.